Marina Morenko

Marina Morenko

Auto-generated profile, based on publicly available information

Marina Morenko

Astana Medical University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2021 in Russian Open Medical Journal
Verified
Journal Article
Open access
AZAdil Zhamankulov
Adil Zhamankulov
RRRafail Rozenson
Rafail Rozenson
MMMarina Morenko
Marina Morenko
KSKseniya Shnayder
Kseniya Shnayder
UAUlzhan Akhmetova
Ulzhan Akhmetova
ATAlina Tyo
Alina Tyo
The study goal was to investigate the COVID-19 clinical course in children with recurrent respiratory infections (RRI) in Nur-Sultan, Kazakhstan. Material and Methods — we conducted the retrospective analysis of 94 children with RRI, diagnosed with COVID-19, in Nur-Sultan, Kazakhstan. The study involved 53 males and 41 females. The inclusion criterion for the study was the frequency of RRI at least six times per year. In the course of our study, we split the patients among three groups and identified two phenotypes. These groups included children with RRI and atopic phenotype (Group 1), with D-deficiency phenotype (Group 2), and control group (Group 3) encompassing children with RRI lacking these phenotypes. Results — The most common symptoms of 94 pediatric patients were dry cough (94.7%), fever (81.9%), along with a loss of appetite and fatigue (76.6%). Malaise was observed in 74.5% cases, rhinorrhea was noted in 71.2% of patients, sore throat was detected in 64.9 % of children, and dyspnea was established in 45.7% of cases. We observed no statistical differences in clinical manifestations of COVID-19 among three groups of children. However, duration of hospitalization period, of fever, and of the catarrhal period differed significantly among the groups (р<0.001). Conclusion — In children with RRI and vitamin D deficiency, who were diagnosed with COVID-19, the course of the infection was unfavorable (which was confirmed by a longer hospital stay and catarrhal period), and a more severe intoxication syndrome was observed. In the group of children with atopic phenotype, a prolonged residual cough was detected.

27 April 2023 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
APA. N. Pampura
A. N. Pampura
EZE. F. Zhukalina
E. F. Zhukalina
MMM. A. Morenko
M. A. Morenko
OUO. P. Usenova
O. P. Usenova
Allergy to cow’s milk proteins is the most common cause of allergic reactions in young children, with a significant impact on the quality of life of children and their families. The most significant biomarker of herbivore milk allergy is allergen-specific IgE (sIgE), which can be assessed both for the whole allergen (for example, cow’s milk (CM), mare’s milk, goat’s milk, etc.) and a specific molecule, included in their composition. This article focuses on the use of sIgE in infants with suspected cow’s milk protein allergy.

15 March 2016 in Journal of Clinical Medicine of Kazakhstan
Verified
Journal Article
Open access
OUOksana Ussenova
Oksana Ussenova
DGDinara Gabdullina
Dinara Gabdullina
MMMarina Morenko
Marina Morenko
YKYelena Kovzel
Yelena Kovzel

28 September 2023 in Russian Open Medical Journal
Verified
Journal Article
Closed access
MSMadina Syzdykova
Madina Syzdykova
MMMarina Morenko
Marina Morenko
MGMadina Gatauova
Madina Gatauova
SZSaule Zhumambayeva
Saule Zhumambayeva
KSKseniya Shnaider
Kseniya Shnaider
Background — Advances in neonatal intensive care have resulted in high survival rates for infants born with extremely low birth weight. Accordingly, the treatment and rehabilitation of premature neonates with bronchopulmonary dysplasia (BPD) is indisputably an urgent problem. Objective — To evaluate the efficacy of vibroacoustic therapy in patients with BPD in the complex of therapeutic measures. Material and Methods — The study was a prospective, non-randomized open-label controlled clinical trial conducted in 2018-2020 in Astana, Kazakhstan. It included 69 children with BPD hospitalized with a concomitant diagnosis of pneumonia between the ages of 1 and 2 years. The study subjects were distributed among two groups: Group 1 (the main group, n=37) receiving vibroacoustic therapy with the VibroLung apparatus in combination with the main treatment and Group 2 (the control, n=32) receiving solely the main treatment. Results — The inclusion of the vibroacoustic method of treatment in the combination therapy of pneumonia in children with BPD resulted in early leveling of the following clinical symptoms: a reduction in the duration of the high fever by 1.18 days vs. the control group (p<0.05), relief of respiratory failure 1.4 days earlier vs. the control group (p<0.05) and a decrease in the duration of inpatient treatment by 2.9 days, compared with the control group (p<0.05). All of these implied the efficacy of this treatment method. Conclusion — Our results demonstrated that vibroacoustic therapy was a relevant addition to the treatment of pneumonia in children with BPD.

5 March 2025 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
APA. N. Pampura
A. N. Pampura
EZE. F. Zhukalina
E. F. Zhukalina
MMM. A. Morenko
M. A. Morenko
OUO. P. Ussenova
O. P. Ussenova
Improvements in clinical approaches and innovative technological solutions in the field of molecular allergy diagnostics have fundamentally changed the tactics and strategy for managing children with allergic diseases. In particular, molecular allergy diagnostics is used to make decisions in cases of suspected food allergy; to assess the risks of life-threatening reactions; to optimize the elimination diet; to identify cross-reactivity; to diagnose inhalant allergies and determine their clinical significance;to provide optimal recommendations for reducing the exposure to inhalation allergens; to rationally select pharmacotherapy and allergen-specific immunotherapy; to predict the course of allergic disease, including the development of the atopic march. In addition, molecular allergy diagnostics is the foundation for establishing a system for preventing allergic diseases. In this article, we have tried to outline the main achievements and prospects of molecular allergy diagnostics application in pediatric practice.

30 April 2026 in Наука и здравоохранение
Verified
Journal Article
Open access
PDF file
АZА.а. Zhamankulov
А.а. Zhamankulov
АBАigerim Baubekova
Аigerim Baubekova
МMМarina Morenko
Мarina Morenko
RRRafail Rozenson
Rafail Rozenson
MGMadina Gatauova
Madina Gatauova
ZSZhanargyl Smailova
Zhanargyl Smailova
Introduction. At the end of December 2019, an outbreak of pneumonia of unknown origin occurred in the city of Wuhan, China. The outbreak was believed to be linked to a local seafood market. In early January 2020, during investigations, a new strain of coronavirus was identified, initially named 2019-nCoV. On February 11, 2020, the virus was officially named SARS-CoV-2, and the disease it causes was named COVID-19. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic as the virus rapidly spread worldwide. Research Objective:To study the clinical and laboratory features of post-COVID syndrome in healthy children who have had SARS-CoV-2. Materials and Methods: A retrospective analysis of 516 medical records and outpatient charts of children who had contracted coronavirus infection between February and August 2020 was conducted. The study included demographic characteristics, clinical manifestations, and laboratory parameters. Statistical analysis was performed using standard biomedical statistical methods. Quantitative variables were presented as mean ± standard deviation (SD), and categorical variables as percentages. Differences were considered statistically significant at p < 0.05. Research Results:A parental survey of children who had recovered from COVID-19 revealed post-COVID-19 syndrome in 33.8% of cases. The predominant symptoms included fatigue, persistent cough, impaired concentration, headaches, and loss of taste and/or smell. Laboratory findings demonstrated reduced levels of vitamin D, leukocytes, lymphocytes, hemoglobin, and ferritin; elevated C-reactive protein (CRP), IgE, and erythrocyte sedimentation rate (ESR); and the presence of anti-SARS-CoV-2 antibodies in 90.2% of the children. Conclusions: Рost-COVID-19 syndrome developed in 33.8% of children following mild or moderate COVID-19, and was characterized by asthenic, respiratory, and cognitive components, accompanied by inflammatory and immunological alterations in laboratory parameters. Введение. В конце декабря 2019 года в городе Ухань, Китай, произошла вспышка пневмонии неизвестного происхождения. Считается, что вспышка была связана с местным рынком морепродуктов. В ходе исследований, проведенных в начале января 2020 года, был идентифицирован новый штамм коронавируса, первоначально названный 2019-nCoV. 11 февраля 2020 года вирус был официально назван SARS-CoV-2, а вызываемое им заболевание получило название COVID-19. 11 марта 2020 года Всемирная организация здравоохранения (ВОЗ) объявила о пандемии COVID-19, поскольку вирус быстро распространялся по всему миру. Цель исследования: изучить особенности клинико-лабораторного течения постковидного синдрома у здоровых детей, перенесших SARS-CoV-2 Материалы и методы: Проведен ретроспективный анализ 516 историй болезни и амбулаторных карт детей, перенесших коронавирусную инфекцию в период с февраля по август 2020 года. Анализ включал демографические характеристики, клинические проявления и лабораторные показатели. Статистическая обработка данных проводилась с использованием стандартных методов биомедицинской статистики. Количественные показатели представлены в виде среднего значения (Mean) ± стандартного отклонения (SD), качественные показатели — в процентах. Статистически значимыми считались различия при p < 0,05. Результаты исследования: Опрос родителей детей, перенёсших COVID-19, выявил постковидный синдром у 33,8% из них. Основные симптомы: слабость, остаточный кашель, снижение концентрации, головные боли, потеря вкуса/обоняния. Лабораторно отмечены снижение витамина D, лейкоцитов, лимфоцитов, гемоглобина, ферритина; повышение СРБ, IgE, СОЭ; антитела к SARS-CoV-2 – у 90,2%. Выводы: Таким образом, у 33,8 % детей, перенесших COVID-19 в лёгкой или среднетяжёлой форме, развивается постковидный синдром, характеризующийся астеническим, респираторным и когнитивным компонентами на фоне воспалительных и иммунологических изменений лабораторных показателей. Кіріспе. 2019 жылдың желтоқсан айының соңында Қытайдың Ухань қаласында шығу тегі белгісіз пневмонияның өршуі болды. Ауру жергілікті теңіз өнімдері нарығымен байланысты деп саналады. 2020 жылдың қаңтар айының басында жүргізілген зерттеулер бастапқыда 2019-nCoV деп аталатын...